DECLARATIONS
Funding: No specific funding was received from any bodies in
the public, commercial or not-for-profit sectors to carry out work
described in this article.
Conflicts of Interest: The authors declare no conflicts of
interest.
Availability of data and material: The Dataset of the study is
available from the corresponding author on reasonable request.
Code availability: Not applicable.
Author contributions: MB designed and planned the study, MB,
MA, MHU, and MİK collected the data, MİK and MB carried out the data
evaluation and basic analyses, all authors contributed to the follow-up
of the patients and interpretation of results. MB wrote the first draft,
and all authors provided critical feedback for the last version.
Ethics approval : Individual written patient consent and local
ethic committee approval was obtained for this study (date/number:
24.02.2022, 2022/04-09).
Word count: 647 words in main text without references
Abstract word count : Not applicable
Number of tables : One
Number of figures: One
References: 8
Acknowledgement: No
Key words: Anakinra, Baricitinib, COVID-19, cytokine storm